Thursday, May 3, 2012

Ford (F) 1Q 2012 Earnings


            On Friday, Ford reported a fall in quarterly profit that beat street expectations.  Since then, the stock price has slid about $1 on macroeconomic concerns: Europe debt worries & disappointing domestic GDP numbers. 
            In the first fiscal quarter of 2012, ford earned $1.4 billion.  This is a large drop from a year earlier--the first quarter of 2011 yielded $2.55 billion in earnings.  Ford incurred higher taxes in the most recent quarter, which dragged down profits with the help of losses in Europe and Asia.  CFO Bob Shanks said that Ford has lowered its guidance on European demand for the next five years and will lose about $500-600 million for this fiscal year.  Guidance for the Asia Pacific area was also lowered.  But, there is some form of a silver lining.  Increased productivity and product launches should still help profitability in the rest of the year.
            Ford showed strength in its domestic market, with an increase in $289 million in pre-tax profit year-over-year.  This is the highest quarterly profit in this division since 2000.  Its operating margins in this area increased 1.2% since 1Q2011 because they have been focusing on a smaller product line.  But, there is a caveat in this improvement.  Ford has lost market share in the U.S., dropping from 16% to 15.2%.
            On April 20th, 2012, Ford announced a $5 billion investment in China.  New dealerships and factories should be completed by 2015. In the conference call, management reaffirmed that although there are some concerns about China’s future growth, middle class consumers’ demand in China is not fully saturated. 

Baxter International (BAX) Q1 Earnings Call


         Baxter International reported earnings for the 3 months ended, March 31st, 2012, with better than anticipated results. First quarter revenue of $3.4 billion beat growth expectations by 2%. Overall, year-over-year revenue increased roughly 4% from $3.3 billion. Also, EPS increased by $0.06 to $1.04 from previously $0.98 in 2011, representing a 6% increase. Both revenue and EPS exceeded BAX’s previous guidance for the year, primarily due to their Bioscience division, which increased recombinant sales by 10%. The increase in this product line was a result of high demand for several hemophilia treatments and the revenue generated from the Synovis Life Technologies Inc. acquisition. Medical Products also grew to $1.9 billion, a 3% increase, driven by strong growth in anesthesia products and certain inject able and nutritional therapies. Unfortunately, the FDA delayed approval of HyQ, an investigational product or immune disorders. The new sent BAX shares down as much as 7%. However, CEO Bob Parkinson conveyed considered BAX’s extensive pipeline, he believes that the “reaction in the market is a total disconnect.” Nevertheless, BAX continued to expand its portfolio and pipeline through investments in R&D and pursuit of business development opportunities. For example, under the Hart-Scott-Rodino Antitrust Improvements Act, Baxter received clearance for its collaboration with Momenta to develop and commercialize follow-on biosimilars. In addition, the FDA approved TISSEL for an expanded indication for general homeostasis in surgery. Among other advancements, BAX has entered 2012 with strong momentum and is confident in their ability to continue their success. That being said, management forecasted even brighter projections for FY2012, including increased sales growth of 4-5% and earnings of $4.49-$4.57 per share.


- Shawn Laljit

Wednesday, May 2, 2012

Apple (AAPL) 2Q 2012 Earnings


            Last Tuesday, Apple’s stock recovered the previous week’s losses after ‘blowout’ second quarter earnings during late-day trading.  The stock gapped up 7%, driven by EPS of $12.30 (almost doubling year-over-year) versus the average estimate of $10.02.  Revenue came in at $39.19 billion (year-over-year growth of 59%) compared to Zack’s Consensus of $36.58 billion.  Gross margin increased 600 basis points to 47.4%.  iPhone sales increased 88% year-over-year to 35.1 million units, fueled by international demand for the iPhone 4S, notably in China.  International sales made up 64% of total revenue in the most recent quarter.  iPod sales fell 15%, as these sales were partially replaced by the hot-selling iPhone & iPad.  Although, CFO Peter Oppenheimer said that the iPod still holds about 70% of the market share of MP3 players.
            iPad sales were up 151% to 11.8 million units.  Although some of these sales cannibalized Mac sales, management insists that this is not a ‘zero-sum game’.  Education & enterprise are two promising markets for future growth.   For example, 94% of Fortune 500 companies have used/tested the iPad in their operations.   Sales to domestic K-12 grades outnumbered Macs by two to one this quarter, after iBooks 2 was introduced in January.  CEO Tim Cook said that the main reason for cutting the iPad 2 price to $399 was to ‘unlock some (price-sensitive) educational demand’.  The iPad occupies about 60% of the tablet market, followed by tablets supporting the Android operating system (32%). 
            China was a clear catalyst for international growth during this quarter.  The iPhone 4S debuted in China in mid-January, as the #3 wireless carrier (China Telecom) was brought into the mix.  This should continue to grow, when China Mobile (#1 carrier) eventually comes into play.  Analysts anticipate Apple to launch a new iPhone (5) this fall, followed by a TV (iPanel) in the winter.  The new iPhone is expected to support 4G service.  Management reiterated (pending board approval) a dividend of $2.65 to be paid out at the end of the next quarter.
            Revenue guidance was lowered for the next fiscal quarter (ending in June).  Production was more efficient than anticipated, so revenue that was anticipated for the next quarter (ending in June) may have been realized in the most recent quarter.  Also, management expects that a strengthening dollar will hurt revenue levels in the next fiscal quarter. 

Monday, April 30, 2012

CLF Q1 2012 Earnings


Cliff Natural Resources (CLF) reported its Q1 2012 earnings on April the 25th. Revenues increased 7% over last year to $1.3 billion including a first quarter record output of 8 million tons of iron ore. CLF’s North American Coal segment returned to profitability and achieved record sales and production volume of 1.4 and 1.7 million tons respectively. Across the board, all segments realized record sales volume, as operational constraints from last year were significantly resolved. Sales volume of the U.S. segment increased 20% to 3.4 million tons from 2.8 million tons, while the East Canadian segment realized an increase of 160% to 1.9 million tons from 730,000 tons. The Asian Pacific region added to overall sales volume by recording a 25% increase to 2.8 million tons from 2.2 million tons in 2011. Despite increases seen in sales volume, pricing and cost conditions withheld expected earnings from materializing. Iron ore prices remained relatively low at $140 price per ton in comparison to last year’s Q1 price per ton of $180. Adding to price pressure was the lack of demand seen in Europe which hampered met coal prices during the quarter. Management expects iron ore prices to remain stable at $150 per ton throughout the remainder of the year. Apart from price conditions, CLF experienced a substantial increase in COGS as mining, maintenance, energy, and transportation cost squeezed earnings in Q1. Management highlights that continued aggressive capacity expansion and one time operational constraints also contributed to overall cost.

Net income depleted by 11% from $423 million in Q1 2011 to $376 million in Q1 2012.  Management maintains its sales volume outlook across all segments including an increase in the Asian Pacific segment of 11.4 million tons from 11 million. Although annual sales volume remains in line, CLF reduced its operational cash flow outlook from $1.9 billion to $1.7 billion, primarily driven by outlook adjustments in full year business segment. Currently, all capacity expansion plans are on schedule, including cost and expected annual output. The Chromite project is slated to advance from the pre-feasibility stage to feasibility this summer as CLF expects to spend $75 million this year. Overall, CapEx is expected to be $1 billion this year including $333 million in dividend payments. The remaining cash will cushion CLF’s liquidity stance as it plans to shore up cash after last year’s acquisition of Consolidated Thompson. In response, shares were down 5.5% after-hours on April the 25th. 

-Kelechi B. Nwokocha

Metlife Inc. Q1 2012 Earnings


Metlife Inc. reported Thursday morning on April the 26th. Net operating earnings were up year over year at $1.46 billion or $1.37 per share compared to $1.32 billion or $1.23 per share one year ago. However Metlife Inc. posted a net loss for the quarter of $174 million due to extraordinary items including $1.3 billion in derivative losses tied to credit spreads and interest rates. The stock declined in after hours on the news but rebounded Friday to recover a majority of the lost ground. International growth was strong, with operating earnings in China posting 33% growth year over year and sales in Japan grew by 28% year over year. Total sales for their entire Asian segment were up 15%, premiums, fees, and other revenues were up 8%. Their EMEA (Europe, Middle East, and South Asia) segment saw operating earnings fall 4% year over year due to unfavorable exchange rates and a difficult economic environment in Europe however despite the environment, premiums, fees, and other revenues grew by 9% in the segment. Latin America saw operating earnings up 33% year over year.

In the conference call management addressed the derivatives loss briefly only to say that “derivative gains and loses related to MetLife’s credit spreads do not have an economic impact on the company.” Management affirmed their direction to free Metlife Inc. of increased regulatory oversight levied though the previously announced sale of Metlife Bank to GE Capital, the spin down of their forward mortgage business, and the newly announced sale of Metlife Inc.’s reversed mortgage to Nationstar Mortgage LLC. While this is good news for the possibility of returning capital to shareholders management dodged questions stating that they could not read the regulators. Management declined to update or affirm 2012 projections. 

Sunday, April 29, 2012

Reliance Steel Q1 2012 Earnings

Reliance Steel & Aluminum Co reported earning on Thursday April 26th. They reported net income of $116.2 million, that's up 26% from the 2011 first quarter net income of $92.3 million and up 71% from $67.9 million in the 2011 fourth quarter. Earnings per diluted share were $1.54 in the 2012 first quarter. That's up 25% from the 2011 first quarter earnings per diluted share of $1.23 and up 69% from $0.91 for the 2011 fourth quarter. The industries that continued to provide the most growth for them where energy, oil and gas, aerospace, heavy equipment and auto through our toll processing businesses. The stock slipped as its outlook for the current quarter lagged Wall Street expectations. "There is still some uncertainty regarding the direction of prices for some of the metals we sell, with prices currently moving in different directions for different products," said Chairman and Chief Executive Officer David Hannah. Reliance expects second-quarter earnings in the range of $1.40 to $1.50 per share, he said. Analysts currently expect $1.53 for the quarter. 

-John Astarita

Parker Hannifin Reports 3Q2012 Earnings

Parker-Hannifin reported Tuesday morning reporting their 3Q2012 Earnings. They recorded record sales, Net Income, and EPS for third quarter results. Net Sales grew to $3.39 Billion, against estimates of $3.28 Billion, while Net Income reached $312 Million, and EPS totaled $2.01 per share, beating expected EPS by 19.6%. They achieved these numbers through an 11.6% increase in North American sales and an increase of 7.7% in the Aerospace Segment. With the relatively positive 3Q2012 earnings, Parker was able to raise their EPS range FY2012 from $6.90-$7.30 a share to $7.30-$7.50 a share. The company also raised their dividend to $.41 a quarter, a 5% increase over the previous number. The stock reacted well, going up 6.99% since the earnings announcement and closed Wednesday at $87.08.
-Matthew Buechele